Showing all 4 results
Fluphenazine Injection
FreeProduct Composition & Strength
We supply this product as a Sterile Oily Solution in Amber Glass Ampoules or Vials.
Active Ingredient Strength Type Fluphenazine Decanoate USP/BP 25 mg 1 ml Ampoule / Vial Fluphenazine Decanoate USP/BP 12.5 mg 0.5 ml Ampoule (Starter Dose) Vehicle Sesame Oil Depot Base Preservative Benzyl Alcohol 1.5% v/v (In Vials) *Pack Sizes: Tray of 5 Ampoules, 10 Ampoules, or 10 ml Multi-Dose Vial.
Olanzapine Injection
FreeProduct Composition & Strength
We supply this product as a Sterile Lyophilized Powder (Yellow Cake) in glass vials.
Active Ingredient Strength Reconstitution Requirement Olanzapine BP/USP 10 mg Requires 2.1 ml of Sterile Water for Injection Excipients Lactose Monohydrate / Tartaric Acid Bulking Agent / Solubilizer *Pack Sizes: Single Vial. (Produces a clear, yellow solution upon reconstitution).
Risperidone Orally Disintegrating (OD) Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Orally Disintegrating Tablet (ODT) / Mouth Dissolving Tablet (MDT), packed exclusively in highly secure, moisture-resistant Alu-Alu or specialized Peelable Blister strips to protect the incredibly fragile, highly porous tablet structure.
Active Ingredient Strength Primary Clinical Function Risperidone INN/Ph.Eur. 1 mg / 2 mg Base titration units for acute agitation and pediatric/geriatric initiation. Risperidone INN/Ph.Eur. 4 mg Global Clinical Standard: High-dose therapy for severe, acute schizophrenic or manic exacerbations. Excipients Mannitol / Crospovidone / Aspartame / Peppermint Flavor / Magnesium Stearate Lyophilized Matrix Base / Superdisintegrant / Sweetener (Engineered to mask the bitter API and melt within seconds on the tongue) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict psychiatric ward dispensing and outpatient compliance regimens).
Ziprasidone Capsules
FreeZiprasidone capsules (widely known by the brand name Geodon) are atypical antipsychotic medications used to treat schizophrenia and bipolar disorder.
